Living with multiple sclerosis means facing an unpredictable journey. Patients often worry about when the next relapse will happen or how much their physical abilities might change over time. New data suggests that measuring a specific protein, called NfL, could offer more clarity on what to expect.
Researchers looked at data from over 4,000 people with multiple sclerosis. They found that higher levels of this NfL protein are linked to an increased risk of relapses and the progression of disability. This link was especially strong for those with a specific type of the condition called RRMS. When NfL levels crossed a certain threshold, the risk of these issues increased significantly.
While another protein, GFAP, was also studied, it did not show the same ability to predict how the disease would progress. For now, NfL stands out as a more sensitive marker for tracking both active relapses and the gradual decline in physical function. Because every person's condition is unique, talk to your doctor about what these markers mean for your specific treatment plan.
